United States:
Coming Soon: Paradigm Shift In Genetic Resources Regs
02 November 2013
WilmerHale
To print this article, all you need is to be registered or login on Mondaq.com.
It has been 20 years in the making, but a new regulatory scheme
is quickly moving into force. This emerging regime may impact the
development of, and intellectual property rights surrounding, an
array of products, including pharmaceuticals, biotech products,
agricultural products, nutritionals, supplements, cosmetics,
perfumes and fragrances and industrial enzymes.
Please click here to view the full text of this
article.
Originally published on Law360, New York (October 28,
2013)
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.